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Summary 
Differential activation of CD4 + T cell subsets in vivo leads to the development of qualitatively 
different effector responses. We identify an approach that allows selective activation of strongly 
Thl-dominated immune responses to protein antigens. Whereas in vivo administration of ovalbumin 
(OVA) induces cytokine synthesis  that is neither Thl nor Th2 dominated, administration of 
glutaraldehyde polymerized, high relative molecular weight OVA (OA-POL) leads to 20-fold 
increase in the ratio of interferon 3' (IFN-3")/IL-4 and IFN-3"/IL-10 synthesis observed after short- 
term, antigen-mediated  restimulation directly ex vivo. In contrast, concurrent in vivo administration 
of anti-IFN-3/mAb and OVA or OA-POL results in marked increases in IL-4 and IL-10,  and 
decreased IFN-3' production, reflecting a polarization of the response towards a Th2-1ike pattern 
of cytokine synthesis. These observations may be useful in clinical settings including hypersensitivity, 
autoimmune diseases, and vaccine development where the ability to actively select specific patterns 
of cytokine gene expression  would be advantageous. 
T 
he pattern of cytokine production elicited after in vivo 
exposure to antigen largely determines the type of effector 
immune responses that develop (1-4). Many antigen-driven 
responses  are characterized  by a reciprocal  relationship be- 
tween delayed hypersensitivity and antibody production (5, 
6). Helper T  cell clones can be classified as Th0, Thl, and 
Th2 on the basis of function and the pattern of cytokine gene 
expression exhibited after polyelonal or antigen-specific stim- 
ulation. Evidence for preferential activation of Thl- or Th2- 
like populations in vivo has been obtained in animal and human 
systems (1-4, 7-9), most strikingly in parasite-induced re- 
sponses. If, as hypothesized, this reflects preferential activa- 
tion of Thl- or Th2-like patterns of cytokine synthesis, respec- 
tively, methods that would allow selective  induction of specific 
patterns of cytokine gene expression could prove useful in 
manipulating de novo and established  immune responses. 
Depending on the reaction conditions selected, products 
with a wide range of immunological characteristics  can be 
obtained after chemical modification of protein antigens with 
glutaraldehyde (10-13).  Glutaraldehyde polymerized OVA 
(OA-POL), soluble OVA polymers of average relative mo- 
lecular weight of 3.5  x  107, inhibits induction of IgE re- 
sponses (14) and abrogates ongoing IgE synthesis  (15) in a 
murine model of human immediate hypersensitivity. Support 
for the hypothesis that it acts by preferentially  activating a 
Thl-like response is provided by the following observations: 
(a) CD4 T cell-dependent 95-99% decreases in OVA-specific 
IgE and 500-1,000-fold increases in IgG2a synthesis after ad- 
ministration of OA-POL but not unmodified OVA before 
(14) or after  (15) OVA (alum) immunization; and (b)  the 
demonstration that in vivo administration of anti-IFN-3' mAb 
XMG 1.2 neutralizes the effects of OA-POL on OVA-specific 
antibody responses (10). Such data provide strong, albeit in- 
direct, evidence that chemical modification of antigen may 
be useful for induction of differential  patterns of cytokine 
synthesis. 
Here,  we report that chemical modification of OVA can 
be used to deliberately and selectively elicit cytokine produc- 
tion characteristic of Thl-dominated responses. Whereas ad- 
ministration of unmodified OVA (intraperitoneally in saline) 
induces cytokine synthesis that is neither Thl nor Th2 domi- 
nated, administration of OA-POL leads to preferential  in- 
duction of Thl-like responses,  as demonstrated by 20-23- 
fold increases in the ratio of IFN-3,/IL-4 or IFN-3,/IL-10 
synthesis. 
Materials and Methods 
Treatment of Mice.  C57BL/6 mice (6-12-wk-old) bred at the 
University  of  Manitoba  breeding facility  or purchased  from Charles 
River Canada (St. Constant, Quebec, Canada), were used in ac- 
cordance with guidelines issued by the Canadian Council on An- 
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virus, and rodent coronaviruses including murine hepatitis virus 
by ELISA (Murine ImmunoComb; Charles River). OA-POL was 
prepared as described (10). Briefly, glutaraldehyde (6% in 0.15 M 
NaC1) was added dropwise to OVA (5 x  recrystallized; ICN Bio- 
chemicals, Montreal, Canada) at 25 mg/ml in 0.1 M acetate buffer 
(pH 5.3), 0.5 pH units above its isoelectric point, to yield a final 
molar ratio of  200:1. After dialysis  and gel filtration (Biogel  A-50m; 
Bio-Rad Laboratories, Mississauga, Ontario, Canada; Vo  =  5  x 
107), OA-POL was recovered as a single, sharp, symmetric peak 
with an average relative molecular weight  of 3.5  x  107. This 
method was developed in preference to previous approaches to 
glutaraldehyde  modification  which have  been found to yield highly 
heterogeneous  mixtures of  reaction products exhibiting diverse  im- 
munological effects  (11-13). OVA or OA-POL treatment consisted 
of three 80/~g injections (i.p.) on days 1, 3, and 5 before killing 
of the mice for culture on day 8. In light of the qualitative  changes 
in cytokine production and antibody responses that are induced 
as a consequence  of adjuvant administration (16, 17), all injections 
were carried out in saline, without adjuvants. Where used, anti- 
IFN-3, treatment consisted  of injections of  purified XMG 1.2 given 
as 250/~g/i.p. injection every day beginning at day -1, one day 
before initiation of  OVA or OA-POL treatment, ending after day 5. 
Cell Culture.  In initial experiments, mice were killed 5-14 d 
after the initial administration of OVA or OA-POL. All of the ex- 
periments reported here were carried out 8 d after initial exposure 
to antigen, a time found to give maximal cytokine responses in 
the short-term culture system used. Spleen cell suspensions were 
cultured at 7.5  x  10~/ml (2 ml/well) alone or with a predeter- 
mined optimal concentration of OVA (1 mg/ml) or ragweed ex- 
tract  (0.5 mg/ml,  provided by Dr.  A.  Sehon, University  of 
Manitoba, Winnipeg, Canada) in 24-well plates (Coming Science 
Products, Rochester, NY) at 37~  in complete  medium (17). Dupli- 
cate cultures were established from the spleen cells of individual 
mice in each group. Culture supernatants were harvested for anal- 
ysis of Ib4 and IFN-')' production at 20-24 h and Ibl0 at 48 h. 
Cytokine Determinations.  IL-4  was determined as described (17), 
using a (4,5-dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium bromide 
(MTT) assay to characterize the responsiveness of CT.4S cells to 
rib4 (provided by Dr. W. Paul, National Institute of Allergy and 
Infectious  Diseases [NIAID], National Institutes of Health [NIH], 
Bethesda, MD) or sample tissue culture supernatants in the pres- 
ence or absence of anti-Ib4 mAb 11Bll to assure specificity.  Ib4- 
deficient medium was used as a negative control. As used here, 
this assay  detects Ib4 at 0.15-0.30 U/m1 and quantitates amounts 
I>0.6 U/m1 while being unresponsive  to IL-2  levels below 100 U/ml. 
SE within any given experiment was usually <5%. 
IFN-~/.  A sandwich ELISA using purified anti-IFN-3, mAbs 
XMG 1.2 and purified, biotinylated R4-6A2 (American Type Cul- 
ture Collection, Rockville,  MD) in combination with streptavidin- 
alkaline phosphatase was carried out as previously described (17). 
Internal standards of IFN-T-containing, Con A-stimulated mouse 
spleen cell supematants, calibrated against World Health Organi- 
zation-NIAID international reference  reagent Gg02-901-533 (pro- 
vided by Dr. C. Laughlin, NIAID, NIH), were included in each 
ELISA. The lower limit of detection is 0.2 U/ml for IFN-3' with 
quantitative measurement of cytokine >10.5 U/ml. SE was <10% 
in most experiments. 
11.,I0.  A dual mAb-based ELISA with purified SXC1 (18) for 
antigen capture (1/zg/ml) and biotinylated-purified SXC2, strep- 
tavidin-alkaline  phosphatase for development was used with IL-10 
levels in culture supernatants determined against a rlL-10 standard. 
The lower limit of detection is 0.2 U/ml, with quantitation  of 
cytokine t>0.5 U/ml. SE was <10%  in most experiments. 
StatisticalAnalysis.  Mean  cytokine  production _+ SEM is shown. 
Statistical significance  was determined using unpaired two-tailed 
Student's t tests. 
Results and Discussion 
Mice were administered unmodified OVA or OA-POL in 
saline and killed 8 d later, after which time short-term cul- 
tures were used to evaluate the pattern of cytokine response. 
Because cytokine production was examined after very short- 
term, antigen-specific  in vitro stimulation directly ex vivo, 
we largely avoided the complications associated with clonal 
expansion or polyclonal activation (17) and were able to focus 
specifically on cytokine production by normal OVA-reactive 
cells. 
As can be seen in Fig. 1, bulk culture of spleen cells ob- 
tained from such donors yielded readily detectable IL-4, IL- 
l0, and IFN-qr responses  after 20-48 h culture. In the ab- 
sence of adjuvant, OVA elicited responses not dominated by 
Thl- or Th2-1ike cytokine gene expression patterns, as demon- 
strated by mean ratios of IFN-~'/IL-4 and IFN-qr/IL-10 syn- 
thesis of 1.23 and 1.07 in six and four experiments, respec- 
tively (Fig. 1). In marked contrast, cuhures established from 
mice injected with OA-POL under the same conditions (in- 
traperitoneally in saline) exhibited markedly reduced, OVA- 
driven IL-4 and IL-10 synthesis and increased IFN-3r produc- 
tion. Collectively, the ratio of antigen-stimulated IFN'y/IL-4 
or IFNT/IL-10 synthesis in groups given OA-POL was in- 
creased some 20-fold relative to that seen in cultures derived 
from groups given unmodified antigen (Fig. 1 B). These data 
provide direct evidence of preferential induction of a Thl- 
dominated cytokine response, at the population level, amongst 
OVA-reactive  T  cells after administration of appropriately 
modified antigen. 
Tissue culture supernatants from cultures without antigen 
added in vitro usuaUy yielded cytokine production below the 
level of detection. Cytokine synthesis above background was 
not obtained in cultures in which an unrelated antigen was 
added (ragweed extract, data not shown), demonstrating the 
antigenic specificity of the expression of these differential pat- 
terns of cytokine synthesis. 
Several studies have demonstrated that the nature of cyto- 
kines present in the local environment at the time of T cell 
activation can strongly influence commitment to a partic- 
ular pattern of cytokine synthesis (19-21). The data presented 
here suggested to us that early induction of IFN-3, produc- 
tion was responsible for driving commitment of the OVA- 
specific response towards a Thl-like pattern of cytokine gene 
expression. To better characterize the dependency of this com- 
mitment on in vivo IFN-3, synthesis elicited at the time of 
initial antigen exposure,  mice were treated with unmodified 
OVA or OA-POL concurrent with anti-IFN-~/mAb. Animals 
were killed 8 d later and cytokine synthesis patterns were 
evaluated as above via overnight in vitro restimulation in the 
presence of OVA. As demonstrated in Fig. 2, concurrent in 
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Figure  1.  Relative production of Thl- and  Th2-associated  cytokines 
after in vivo administration  of native or chemically modified OVA. (.4)  ;30- 
8 d after intraperitoneal  administration  of OVA or OA-POL, cytokine syn- 
thesis was determined  in 20-48-h, OVA-stimulated (1 mg/ml) bulk cul- 
tures  as described  in Materials and Methods.  Data represent  one of six 
independent  experiments performed.  (/3) The ratio of IFN-'y/IL-4 or IFN- 
3,/I1.-10 synthesis was determined  for the cultures described above. Data 
represent  mean ratios  _+  SEM of six independent  experiments  for IFN-  30- 
T/IL-4, four for IFN-'y/IL-10. 
vivo administration of anti-IFN-'y mAb and OA-POL results 
in marked increases  in IL-4 and IL-10 production and decreases 
in IFN-3' production in response to antigen. This results in 
a reversal from a mean 8:1 ratio of IFN-'y/IL-4/10 synthesis 
in OA-POL-treated groups to a mean ratio of 0.26 after con- 
current OA-POL/anti-IFN-3, treatment. 
Concurrent anti-IFN-3,/OVA  administration results  in 
similar polarization of the response towards a Th2-dominated 
pattern of cytokine synthesis. Of interest was the observa- 
tion that in vivo treatment with anti-IFN-3'  treatment and 
OVA or OA-POL led to similar increases in IL-4 and IL-IO 
synthesis even in the absence of antigen in vitro (data not 
shown). Collectively, these data support the hypothesis that 
the balance of cytokine production that is elicited in the very 
early stages of antigen stimulation in vivo plays a pivotal role 
in determining the nature of the T  cell response that ulti- 
mately comes to dominate the mature cytokine and effector 
responses to that antigen (19-22). 
Whereas it remains  unclear if commitment by normal 
individual T cells is as polarized in vivo as is commonly ob- 
served in long-term Thl and Th2 clones, it is well estab- 
lished that certain antigens inherently induce dominantly  Thl- 
or Th2-1ike responses in vivo (23, 24). In contrast, the present 
results demonstrate a capacity to selectively elicit either type 
of response by appropriate chemical modification of antigen. 
The mechanism by which polymerized and unmodified 
OVA elicit qualitatively different patterns of cytokine syn- 
thesis remains unclear. Good evidence has been obtained that 
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Figure  2.  In vivo administration  of anti-IFN-'y mAb concurrent with 
OVA or OA-POL treatment leads to induction of Th2-dominated responses. 
Cytokine production in 20-48  h.  Supernatants  of cultures  established 
8 d after treatment was determined as described in Materials and Methods. 
aqueous  (unmodified)  antigen administered  in a protocol 
similar to that used here leads to dominance of a Th2 re- 
sponse resulting from clonal anergy of Thl cells and IL- 
4-mediated crossregulation (25). Our finding that anti-IFN-'y 
treatment coadministered  with OA-POL in vivo leads to 
marked increases in IL-4 production argues against  direct 
anergy induction of Th2 cells in this system, and appears more 
consistent with preferential or positive selection of Thl ac- 
tivity rather than negative selection or anergy induction in 
OVA-reactive Th2-1ike cells. 
Particularly intriguing is the hypothesis that antigen pre- 
sentation via B cells favors development of Th2-dominated 
351  Yang et al.  Brief Definitive Report responses whereas macrophages support commitment to Thl 
(26). We speculate that OA-POL, which is of very high rela- 
tive molecular weight and exhibits 10-100-fold  lower anti- 
genicity than unmodified OVA,  may induce a pattern of 
cytokine synthesis in vivo that is distinct from that seen after 
administration of native OVA because  of minimal antigen 
presentation by OVA-specific B cells. In contrast, the very 
high relative molecular weight of OA-POL may enhance its 
processing by macrophages, contributing to a preferential ac- 
tivation of Thl-like activity. Experiments comparing the pat- 
tern of cytokine synthesis obtained in B cell-deficient (chron- 
ically anti-/~ treated) mice after administration of native and 
chemically modified antigen are currently underway to ad- 
dress  this issue. 
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